Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppression For Disease”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Large-scale testing (Phase 3)Ended earlyNCT01408836
What this trial is testing

Plasma Exchange for Renal Vasculitis

Who this might be right for
Wegener's GranulomatosisMicroscopic Polyangiitis
Cambridge University Hospitals NHS Foundation Trust 150
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07578558
What this trial is testing

NAI for Sepsis With Persistent Lymphopenia

Who this might be right for
SepsisSeptic ShockLymphopenia+2 more
ImmunityBio, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61
Post-approval studies (Phase 4)Study completedNCT01964014
What this trial is testing

Once-a-day Immunosuppression(CISECON_a_day)

Who this might be right for
Chronic Renal Disease
Ajou University School of Medicine 160
Early research (Phase 1)Study completedNCT02560220
What this trial is testing

MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Failure, Chronic
Heidelberg University 14
Large-scale testing (Phase 3)Ended earlyNCT01213394
What this trial is testing

Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationCardiovascular Diseases
Ramesh Prasad 2
Not applicableLooking for participantsNCT07184853
What this trial is testing

Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

Who this might be right for
Graft vs Host Disease
First Affiliated Hospital of Zhejiang University 122
Early research (Phase 1)Study completedNCT00010335
What this trial is testing

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Who this might be right for
Systemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more
Fred Hutchinson Cancer Center 6
Not applicableStudy completedNCT00273390
What this trial is testing

A Clinical Trial of Infliximab for Uveitis

Who this might be right for
Uveitis
Oregon Health and Science University 32
Not applicableLooking for participantsNCT04521790
What this trial is testing

Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management

Who this might be right for
MyocarditisVentricular ArrythmiaInflammatory Cardiomyopathy+6 more
Scientific Institute San Raffaele 1,000
Post-approval studies (Phase 4)Study completedNCT00812123
What this trial is testing

Calcineurin Free Immunosuppression in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationChronic Kidney Disease
University Hospital, Basel, Switzerland 127
Large-scale testing (Phase 3)Looking for participantsNCT05415267
What this trial is testing

Immunosuppression and COVID-19 Boosters

Who this might be right for
COVID-19
Kirby Institute 320
Testing effectiveness (Phase 2)Study completedNCT00001863
What this trial is testing

Leflunomide to Treat Uveitis

Who this might be right for
Uveitis
National Eye Institute (NEI) 16
Early research (Phase 1)Study completedNCT00001630
What this trial is testing

Treatment of Autoimmune Thrombocytopenia (AITP)

Who this might be right for
Autoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Study completedNCT00005801
What this trial is testing

Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT00021788
What this trial is testing

Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableUnknownNCT01902030
What this trial is testing

Evaluation of Performance of An Aspergillus PCR in Tissue and Pleural Effusion Samples of Immunocompromised Patients

Who this might be right for
AspergillosisImmunosuppression
Heidelberg University 100
Post-approval studies (Phase 4)Study completedNCT00123331
What this trial is testing

Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation

Who this might be right for
Heart TransplantationRenal Failure
Heidelberg University 40
Next Page